Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure

scientific article published on 01 August 2007

Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3171/SPI-07/08/151
P698PubMed publication ID17688054

P50authorJeffrey WeinbergQ42636015
Charles S CleelandQ88086168
P2093author name stringAnita Mahajan
Ehud Mendel
Laurence D Rhines
Pamela K Allen
Eric L Chang
Shiao Y Woo
Xin Shelly Wang
Moshe H Maor
Almon S Shiu
Barry W Brown
Leni A Mathews
P433issue2
P304page(s)151-160
P577publication date2007-08-01
P1433published inJournal of Neurosurgery-SpineQ15752109
P1476titlePhase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure
P478volume7

Reverse relations

cites work (P2860)
Q41645384A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer
Q36491373A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?
Q42202755A single-dose conformal delivery of radiotherapy following osteoplasty : a novel approach to treatment of osteolytic metastasis in the setting of multiple myeloma
Q39771088A survey of stereotactic body radiotherapy use in the United States
Q38790915A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer
Q36534796Accuracy of marketing claims by providers of stereotactic radiation therapy
Q47587062An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report.
Q34985841CT-guidance interstitial (125)Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors
Q39329017Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy
Q41117173Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases
Q50225647Clinical outcomes of multileaf collimator-based CyberKnife for spine stereotactic body radiation therapy.
Q36166881Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
Q30428253Clinical practice of image-guided spine radiosurgery--results from an international research consortium
Q44946517Commissioning and initial stereotactic ablative radiotherapy experience with Vero
Q36200258Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design
Q91305199Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases
Q35121736Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer
Q30275416Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine
Q30275436Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
Q38421253Contemporary treatment with radiosurgery for spine metastasis and spinal cord compression in 2015.
Q36639798Conventionally-fractionated image-guided intensity modulated radiotherapy (IG-IMRT): a safe and effective treatment for cancer spinal metastasis
Q42557288Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases
Q30467551Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view
Q90682121Decision Making in Patients With Metastatic Spine. The Role of Minimally Invasive Treatment Modalities
Q35318609Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers
Q38628837Dose Evaluation of Fractionated Schema and Distance From Tumor to Spinal Cord for Spinal SBRT with Simultaneous Integrated Boost: A Preliminary Study.
Q37876669Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
Q52677059Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study.
Q38629152Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
Q50875641Dosimetric comparison of Acuros XB with collapsed cone convolution/superposition and anisotropic analytic algorithm for stereotactic ablative radiotherapy of thoracic spinal metastases.
Q47157174Dosimetric evaluation of target coverage as a predictor of local failure following stereotactic body radiation therapy for spinal tumors
Q47160855Dosimetric impact of angular deviations in positioning for spinal radiosurgery
Q90279869Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy
Q39098306Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results
Q47326988Estimating normal tissue toxicity in radiosurgery of the CNS: application and limitations of QUANTEC.
Q92134450Evaluation of Elements Spine SRS Plan Quality for SRS and SBRT Treatment of Spine Metastases
Q36243980Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
Q35970973Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach
Q83856551Follow-up CT and MR findings of osteoblastic spinal metastatic lesions after stereotactic radiotherapy
Q34481244Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial
Q36196005Helical tomotherapy for spine oligometastases from gastrointestinal malignancies
Q92864450Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis
Q30491424Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions
Q43120283Influence of rotations on dose distributions in spinal stereotactic body radiotherapy (SBRT).
Q47102842Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery
Q47143635Investigating the dosimetric effects of grid size on dose calculation accuracy using volumetric modulated arc therapy in spine stereotactic radiosurgery
Q45333139Irradiation of Spinal Metastases: Should We Continue to Include One Uninvolved Vertebral Body Above and Below in the Radiation Field?
Q44251937Is helical tomotherapy accurate and safe enough for spine stereotactic body radiotherapy?
Q64251198Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases
Q64997111Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases.
Q88425219Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity
Q39204909Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases
Q36718847Metachronous presentation of metastasis from renal cell carcinoma: evaluation and management of spinal metastasis
Q39441188Modern approaches to the management of metastatic epidural spinal cord compression
Q60046002Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
Q30484881Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Q88241543Oropharyngeal Dysphagia Evaluation Tools in Adults with Solid Malignancies Outside the Head and Neck and Upper GI Tract: A Systematic Review
Q97541985Outcome and toxicity of hypofractionated image-guided SABR for spinal oligometastases
Q35190502Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases
Q30426369Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review
Q36793780Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases
Q41967061Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy
Q35750652Prevention and Treatment of Bone Metastases in Breast Cancer
Q39185475Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy
Q37841372Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience
Q47146254Prospective validation of treatment accuracy using implanted fiducial markers for spinal stereotactic body radiation therapy
Q30416741Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
Q37011543RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results
Q38685466Radiobiology of stereotactic body radiation therapy (SBRT).
Q36582921Radiosurgery Compared with External Radiation Therapy as a Primary Treatment in Spine Metastasis from Hepatocellular Carcinoma : A Multicenter, Matched-Pair Study
Q37534318Radiosurgery for spinal malignant tumors
Q43897534Radiosurgery using the Cyberknife for benign spinal tumors: Korea Cancer Center Hospital experience
Q26864247Review and uses of stereotactic body radiation therapy for oligometastases
Q39251763Review of stereotactic radiosurgery for intradural spine tumors
Q47133015Risk of vertebral compression fracture specific to osteolytic renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study
Q38872884Robotic Radiosurgery for the Treatment of Intramedullary Spinal Cord Metastases: A Case Report and Literature Review
Q52624075Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era.
Q38233126Role of stereotactic body radiotherapy in spinal metastasis and subsequent fracture risk: identifying and treating the at-risk patient
Q52945416Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy.
Q91738235Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
Q34781650Spinal cord tolerance in the age of spinal radiosurgery: lessons from preclinical studies
Q38677022Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT.
Q35690484Spinal radiosurgery--efficacy and safety after prior conventional radiotherapy
Q47121395Spinal radiosurgery: a neurosurgical perspective
Q37278149Spinal radiosurgery: technology and clinical outcomes.
Q39308768Spine Stereotactic Body Radiotherapy: Indications, Outcomes, and Points of Caution
Q83862664Spine instrumentation failure after spine tumor resection and radiation: comparing conventional radiotherapy with stereotactic radiosurgery outcomes
Q47134226Spine radiosurgery for spinal cord compression: the radiation oncologist's perspective
Q28079505Spine radiosurgery for the local treatment of spine metastases: Intensity-modulated radiotherapy, image guidance, clinical aspects and future directions
Q57826816Stereotactic Body Radiation Therapy for Spinal Malignancies
Q64074521Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
Q38917489Stereotactic Body Radiotherapy for Spinal Metastases: What are the Risks and How Do We Minimize Them?
Q47140283Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control
Q42700730Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture
Q57177641Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions
Q28709611Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial
Q37790167Stereotactic body radiation therapy for spinal metastases
Q37649474Stereotactic body radiation therapy: a novel treatment modality
Q35687568Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review
Q36915978Stereotactic body radiotherapy for lesions of the spine and paraspinal regions
Q41340312Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
Q45170619Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
Q39044493Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review
Q41910000Stereotactic body radiotherapy for solitary spine metastasis
Q38046079Stereotactic body radiotherapy treatment of extracranial metastases
Q39207551Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study
Q34811295Stereotactic radiosurgery for spinal metastases: a literature review
Q37544922Stereotactic radiosurgery in the management of cancer pain
Q46022001Submillimeter alignment of more than three contiguous vertebrae in spinal SRS/SBRT with 6-degree couch.
Q36396372Survival-Related Factors of Spinal Metastasis with Hepatocellular Carcinoma in Current Surgical Treatment Modalities : A Single Institute Experience
Q37409902The Effect of Perioperative Radiation Therapy on Spinal Bone Fusion Following Spine Tumor Surgery
Q41450381The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.
Q38109622The NOMS framework: approach to the treatment of spinal metastatic tumors
Q55223014The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Q38009256The role of radiation therapy in controlling painful bone metastases
Q26823733The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer
Q35794711The role of stereotactic radiosurgery in metastasis to the spine.
Q38233173Update on management of vertebral column tumors.
Q40427837Value of postoperative stereotaxic body radiation therapy for spinal metastases
Q37097528Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014
Q36228265What Is the Value of Surgical Intervention for Sacral Metastases?
Q38983894When Less Is More: The indications for MIS Techniques and Separation Surgery in Metastatic Spine Disease.

Search more.